治療結果と中枢神経系の再発リスク 主要皮膚性DLBCLの患者で,リトキシマブ時代
Giulio Cassanello1,2, Esther Drill3, Annie Qiu1
1Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Blood cancer journal
|August 29, 2025
まとめ
No abstract available in PubMed .
さらに関連する動画
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.6K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.6K
